Vabomere (meropenem / vaborbactam) is a combination antibiotic medication used to treat complicated urinary tract infections, including those affecting the kidneys. It's a broad-spectrum antibiotic, which means that it works against many types of bacteria. Vabomere (meropenem / vaborbactam) is given as an intravenous (IV) infusion by a healthcare provider.
Treatment of complicated urinary tract infections (UTIs), including those affecting the kidneys, in adults
Vabomere (meropenem / vaborbactam) is a combination of two medications.
Meropenem is a carbapenem antibiotic. It kills bacteria by preventing them from making their own protective covering.
Vaborbactam is a beta-lactamase inhibitor. It blocks the activity of beta-lactamase, an enzyme (protein) made by bacteria that often breaks down certain antibiotics, like meropenem. Vaborbactam helps protect meropenem from the action of beta-lactamase and allows the antibiotic to work as it should.
Source: DailyMed
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report to your care team if they continue or are bothersome):
Able to kill certain bacteria that are resistant to (harder to treat with) other antibiotics
Can use for people who have kidney disease and people who are on dialysis
Might work well for people who didn’t see benefits with other antibiotics for complicated UTI
Typically mild day-to-day side effects
Unknown if safe or works well in children
Can raise the risk of seizures
Only available as an IV infusion
Might not be safe to use if you're allergic to penicillin
Before getting Vabomere (meropenem / vaborbactam) treatment, tell your provider if you're allergic to penicillins, cephalosporins, or any other antibiotics. This is because serious allergic reactions to Vabomere (meropenem / vaborbactam) can happen if you have a history of allergies to these medications.
Before starting Vabomere (meropenem / vaborbactam), your provider will check to make sure this medication works against the bacteria that's causing your infection. Taking Vabomere (meropenem / vaborbactam) or other antibiotics when they aren't necessary can cause the bacteria to become resistant to antibiotics, which can make your infection much harder to treat.
It takes about 3 hours to receive the full dose of Vabomere (meropenem / vaborbactam).
If you have kidney problems, receiving Vabomere (meropenem / vaborbactam) might cause your platelet levels to drop (thrombocytopenia). This is usually not dangerous and doesn't raise your risk of bleeding. Nonetheless, let your provider know if you seem to be bleeding more frequently and easily, have purple spots on your skin, bruising without a cause, or have extreme weakness.
Your provider will give you Vabomere (meropenem / vaborbactam) for the shortest amount of time possible to treat your infection. If you use Vabomere (meropenem / vaborbactam) for too long, it can cause new fungal or bacterial infections to develop that might be harder to treat. Let your provider know if you notice symptoms of a new infection or if the original symptoms don't get better after you've finished your entire course of Vabomere (meropenem / vaborbactam).
Vabomere (meropenem / vaborbactam) can sometimes cause confusion, headache, or abnormal twitching. If you're receiving this medication outside of a hospital, don't drive a car or operate machinery after your infusion until you know how this medication affects you.
Make sure you get any ordered blood tests done on time while you're receiving Vabomere (meropenem / vaborbactam). These blood tests check your kidney health, which help your provider decide whether your dose needs to be adjusted. This makes sure the medication is safe for you to take.
Vabomere (meropenem / vaborbactam) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Risk factors: History of allergy to penicillin, cephalosporin antibiotics, or other beta-lactam antibiotics | History of multiple allergies
Vabomere (meropenem / vaborbactam) can sometimes cause serious allergic reactions, such as rash, swelling, trouble breathing, dizziness, or wheezing. The risk is higher if you've had a history of allergy to penicillin antibiotics, cephalosporin antibiotics, or have multiple allergies. Before starting treatment with Vabomere (meropenem / vaborbactam), make sure to let your provider know about your medical history. If you experience an allergic reaction to Vabomere (meropenem / vaborbactam), get medical care right away. Your provider will stop the infusion and consider other treatment options.
Risk factors: History of seizures | Bacterial meningitis (brain inflammation) | History of brain or kidney problems
Meropenem in Vabomere (meropenem / vaborbactam) can make you more likely to have seizures. The risk might be higher if you have a history of seizures, brain problems, bacterial meningitis, or worsening kidney function. Your provider will make sure you receive the appropriate amount of medication given your kidney health.
If you have a history of seizures, your provider might ask you to continue your anti-seizure medications during treatment with Vabomere (meropenem / vaborbactam). Keep in mind that antibiotics, such as meropenem in Vabomere (meropenem / vaborbactam), have been shown to lower the amount of divalproex (Depakote) and valproic acid in your body. This might make these anti-seizure medications not work as well. Let your provider know if you're using these medications for seizures before starting antibiotic treatment.
Get medical attention right away if you experience sudden jerking or twitching that can't be controlled. This can be a sign that you're having a seizure.
Antibiotics, such as Vabomere (meropenem / vaborbactam), can raise the risk of getting a bacterial infection called Clostridioides difficile (C. diff). This infection can cause severe diarrhea for up to 2 months after your last dose of your antibiotic treatment. To lower your risk of C. diff-related diarrhea, your provider will prescribe the lowest dose of Vabomere (meropenem / vaborbactam) for the shortest amount of time that works well for you. If you experience severe or watery diarrhea, bloody stools, fever, belly pain, loss of appetite, or nausea, let your provider know right away.
Rarely, Vabomere (meropenem / vaborbactam) can affect your mental alertness or your muscle control. Watch out for abnormal twitching or jerking, confusion, headache, or skin tingling, and let your provider know right away. If you're receiving Vabomere (meropenem / vaborbactam) at home or at a provider's office, don't drive a car or operate machinery until you know how this medication affects you.
This medication is only available as an IV infusion that's administered by a healthcare provider. The dose of Vabomere (meropenem / vaborbactam) depends on your kidney health. In general, the typical dose is 4 grams (2 grams of meropenem and 2 grams of vaborbactam) injected into a vein every 8 hours for up to 14 days.
If you're on dialysis and need to get your antibiotic infusions on a dialysis day, your doses of Vabomere (meropenem / vaborbactam) will be given after you have your dialysis session.
Allergy to beta-lactam antibiotics, such as penicillins and cephalosporins
Treatment of complicated urinary tract infections (UTIs), including those affecting the kidneys, in adults
Stomach infection in people ages 2 months and older
Pneumonia in people ages 2 months and older
Skin infection (e.g., cellulitis, foot infection due to diabetes) in adults
Pelvic infection in adult females
By signing up, I agree to GoodRx's Terms and Privacy Policy, and to receive marketing messages from GoodRx.
Khanna, N. R., et al. (2022). Beta-lactamase inhibitors. StatPearls.
Melinta Therapeutics, LLC. (2023). The efficacy of Vabomere® was proven against a widely used anti-infective agent1,2.
Melinta Therapeutics, LLC. (2023). Vabomere- meropenem-vaborbactam injection, powder, for solution [package insert]. DailyMed.
National Heart, Lung, and Blood Institute. (2022). Thrombocytopenia.
National Kidney Foundation. (n.d.). Dialysis.
Norris, A. H., et al. (2018). Clinical practice guideline for the management of outpatient parenteral antimicrobial therapy: 2018 IDSA. Clinical Infectious Diseases.
Papp-Wallace, K. M., et al. (2011). Carbapenems: Past, present, and future. Antimicrobial Agents and Chemotherapy.
Sabih, A., et al. (2023). Complicated urinary tract infections. StatPearls.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.